Russell W Madison (Russell Madison)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 25

Top Topics

Squamous Cell Carcinoma

Dna Methylation

Circulating Tumor

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

JCO precision oncology

BJU international

Future oncology (London, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Christian D Rolfo, Russell W Madison, Lincoln W Pasquina, Derek W Brown, Yanmei Huang, Jason D Hughes, Ryon P Graf, Geoffrey R Oxnard, Hatim Husain
Measurement of ctDNA Tumor Fraction Identifies Informative Negative Liquid Biopsy Results and Informs Value of Tissue Confirmation. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (11) (2024)
Alessandro Russo, Jessica K Lee, Lincoln W Pasquina, Marzia Del Re, Holli H Dilks, Karthikeyan Murugesan, Russell W Madison, Yi Lee, Alexa B Schrock, Leah A Comment, Martin Dietrich, Geoffrey R Oxnard, Christian D Rolfo
Liquid Biopsy of Lung Cancer Before Pathological Diagnosis Is Associated With Shorter Time to Treatment. JCO precision oncology 8 (2024)
Alessandro Russo, Jessica K Lee, Lincoln W Pasquina, Marzia Del Re, Holli H Dilks, Karthikeyan Murugesan, Russell W Madison, Yi Lee, Alexa B Schrock, Leah A Comment, Martin Dietrich, Geoffrey R Oxnard, Christian D Rolfo
Liquid Biopsy of Lung Cancer Before Pathological Diagnosis Is Associated With Shorter Time to Treatment. JCO precision oncology 8 (2024)
Alessandro Russo, Jessica K Lee, Lincoln W Pasquina, Marzia Del Re, Holli H Dilks, Karthikeyan Murugesan, Russell W Madison, Yi Lee, Alexa B Schrock, Leah A Comment, Martin Dietrich, Geoffrey R Oxnard, Christian D Rolfo
Liquid Biopsy of Lung Cancer Before Pathological Diagnosis Is Associated With Shorter Time to Treatment. JCO precision oncology 8 (2024)
Christian D Rolfo, Russell W Madison, Lincoln W Pasquina, Derek W Brown, Yanmei Huang, Jason D Hughes, Ryon P Graf, Geoffrey R Oxnard, Hatim Husain
Measurement of ctDNA Tumor Fraction Identifies Informative Negative Liquid Biopsy Results and Informs Value of Tissue Confirmation. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Christian D Rolfo, Russell W Madison, Lincoln W Pasquina, Derek W Brown, Yanmei Huang, Jason D Hughes, Ryon P Graf, Geoffrey R Oxnard, Hatim Husain
Measurement of ctDNA Tumor Fraction Identifies Informative Negative Liquid Biopsy Results and Informs Value of Tissue Confirmation. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (11) (2024)
Christian D Rolfo, Russell W Madison, Lincoln W Pasquina, Derek W Brown, Yanmei Huang, Jason D Hughes, Ryon P Graf, Geoffrey R Oxnard, Hatim Husain
Measurement of ctDNA Tumor Fraction Identifies Informative Negative Liquid Biopsy Results and Informs Value of Tissue Confirmation. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (11) (2024)
Felipe Batalini, Russell W Madison, Ethan S Sokol, Dexter X Jin, Kuei-Ting Chen, Brennan Decker, Dean C Pavlick, Garrett M Frampton, Gerburg M Wulf, Judy E Garber, Geoffrey R Oxnard, Alexa B Schrock, Nadine M Tung
Homologous Recombination Deficiency Landscape of Breast Cancers and Real-World Effectiveness of Poly ADP-Ribose Polymerase Inhibitors in Patients With Somatic BRCA1 / 2 , Germline PALB2 , or Homologous Recombination Deficiency Signature. JCO precision oncology 7 (2023)
Kuei-Ting Chen, Russell W Madison, Jay Moore, Dexter Jin, Zoe Fleischmann, Justin Newberg, Alexa Schrock, Neeru Bhardwaj, Katherine T Lofgren, Jie He, Garrett Frampton, Priti Hegde, David Fabrizio, Michael J Pishvaian, Ericka Ebot, Aatur Singhi, Ethan Sokol
A Novel HRD Signature Is Predictive of FOLFIRINOX Benefit in Metastatic Pancreatic Cancer. The oncologist (2023)
Bruna Pellini, Russell W Madison, Merrida Childress, Shoshana T Miller, Ole V Gjoerup, Jason Cheng, Richard S P Huang, Michael Krainock, Pratyush Gupta, Wei Zou, David S Shames, Solomon Moshkevich, Marcus Ballinger, Minetta C Liu, Amanda G Young, Minu K Srivastava, Geoffrey R Oxnard, Mark A Socinski
Circulating Tumor DNA Monitoring on Chemo-immunotherapy for Risk Stratification in Advanced Non-Small Cell Lung Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Jay A Moore, Kuei-Ting Chen, Russell W Madison, Justin Y Newberg, Zoe Fleischmann, Shuoguo Wang, Radwa Sharaf, Karthikeyan Murugesan, Bernard J Fendler, Jason Hughes, Alexa B Schrock, Priti S Hegde, Geoffrey R Oxnard, David Fabrizio, Garrett M Frampton, Emmanuel S Antonarakis, Ethan S Sokol, Dexter X Jin
Pan-Cancer Analysis of Copy-Number Features Identifies Recurrent Signatures and a Homologous Recombination Deficiency Biomarker to Predict Poly (ADP-Ribose) Polymerase Inhibitor Response. JCO precision oncology 7 (2023)
Parvathi A Myer, Jessica K Lee, Russell W Madison, Kith Pradhan, Justin Y Newberg, Carmen R Isasi, Samuel J Klempner, Garrett M Frampton, Jeffery S Ross, Jeffrey M Venstrom, Alexa B Schrock, Sudipto Das, Leonard Augenlicht, Amit Verma, John M Greally, Srilakshmi M Raj, Sanjay Goel, Siraj M Ali
The Genomics of Colorectal Cancer in Populations with African and European Ancestry. Cancer discovery 12 (5) (2022)
Russell W Madison, Xiaoju Hu, Vivek Ramanan, Zhuxuan Xu, Richard S P Huang, Ethan S Sokol, Garrett M Frampton, Alexa B Schrock, Siraj M Ali, Shridar Ganesan, Subhajyoti De
Clustered 8-Oxo-Guanine Mutations and Oncogenic Gene Fusions in Microsatellite-Unstable Colorectal Cancer. JCO precision oncology 6 (2022)
Daniel Zingg, Jinhyuk Bhin, Julia Yemelyanenko, Sjors M Kas, Frank Rolfs, Catrin Lutz, Jessica K Lee, Sjoerd Klarenbeek, Ian M Silverman, Stefano Annunziato, Chang S Chan, Sander R Piersma, Timo Eijkman, Madelon Badoux, Ewa Gogola, Bjørn Siteur, Justin Sprengers, Bim de Klein, Richard R de Goeij-de Haas, Gregory M Riedlinger, Hua Ke, Russell W Madison, Anne Paulien Drenth, Eline van der Burg, Eva Schut, Linda Henneman, Martine H van Miltenburg, Natalie Proost, Huiling Zhen, Ellen Wientjens, Roebi de Bruijn, Julian R de Ruiter, Ute Boon, Renske de Korte-Grimmerink, Bastiaan van Gerwen, Luis Féliz, Ghassan K Abou-Alfa, Jeffrey S Ross, Marieke van de Ven, Sven Rottenberg, Edwin Cuppen, Anne Vaslin Chessex, Siraj M Ali, Timothy C Burn, Connie R Jimenez, Shridar Ganesan, Lodewyk F A Wessels, Jos Jonkers
Truncated FGFR2 is a clinically actionable oncogene in multiple cancers. Nature 608 (7923) (2022)
Hope S Rugo, Kira Raskina, Alexa B Schrock, Russell W Madison, Ryon P Graf, Ethan S Sokol, Smruthy S Sivakumar, Jessica K Lee, Virginia A Fisher, Geoffrey R Oxnard, Hanna Tukachinsky
Biology and targetability of the extended spectrum of PIK3CA mutations (PIK3CAm) detected in breast carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Ibiayi Dagogo-Jack, Russell W Madison, Jochen K Lennerz, Kuei-Ting Chen, Julia F Hopkins, Alexa B Schrock, Lauren L Ritterhouse, Ashley Lester, Keith A Wharton, Mari A Mino-Kenudson, Natalie Danziger, Yin P Hung, Douglas A Mata, Jeffery S Ross
Molecular Characterization of Mesothelioma: Impact of Histologic Type and Site of Origin on Molecular Landscape. JCO precision oncology 6 (2022)
Matthew Margolis, Tyler Janovitz, Jason Laird, Douglas A Mata, Meagan Montesion, Jessica K Lee, Russell W Madison, Alexa B Schrock, Hanna Tukachinsky, Justin M Allen, Rachel Erlich, Matthew C Hiemenz, Richard S P Huang, Julia Elvin, Jo-Anne Vergilio, Douglas I Lin, Jeffery S Ross, Geoffrey Oxnard, Brennan Decker
Activating IGF1R hotspot non-frameshift insertions define a novel, potentially targetable molecular subtype of adenoid cystic carcinoma. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 35 (11) (2022)
Hatim Husain, Dean C Pavlick, Bernard J Fendler, Russell W Madison, Brennan Decker, Ole V Gjoerup, Christine A Parachoniak, Margaret E McLaughlin-Drubin, Rachel L Erlich, Alexa B Schrock, Garrett M Frampton, Meghna Das Thakur, Geoffrey R Oxnard, Hanna Tukachinsky
Tumor Fraction Correlates With Detection of Actionable Variants Across > 23,000 Circulating Tumor DNA Samples. JCO precision oncology 6 (2022)
Hanna Tukachinsky, Russell W Madison, Jon H Chung, Ole V Gjoerup, Eric A Severson, Lucas Dennis, Bernard J Fendler, Samantha Morley, Lei Zhong, Ryon P Graf, Jeffery S Ross, Brian M Alexander, Wassim Abida, Simon Chowdhury, Charles J Ryan, Karim Fizazi, Tony Golsorkhi, Simon P Watkins, Andrew D Simmons, Andrea Loehr, Jeffrey M Venstrom, Geoffrey R Oxnard
Genomic Analysis of Circulating Tumor DNA in 3,334 Patients with Advanced Prostate Cancer Identifies Targetable BRCA Alterations and AR Resistance Mechanisms. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (11) (2021)
Jessica K Lee, Mehlika Hazar-Rethinam, Brennan Decker, Ole Gjoerup, Russell W Madison, Daniel S Lieber, Jon H Chung, Alexa B Schrock, James Creeden, Jeffrey M Venstrom, Brian M Alexander, Geoffrey R Oxnard
The pan-tumor landscape of targetable kinase fusions in circulating tumor DNA. Clinical cancer research : an official journal of the American Association for Cancer Research (2021)
Stacey M Stein, Jeremy Snider, Siraj M Ali, Rebecca A Miksad, Brian M Alexander, Emily H Castellanos, Alexa B Schrock, Russell W Madison, Akshay Swaminathan, Jeffrey M Venstrom, Margaret McCusker
Real-world association of HER2/ERBB2 concordance with trastuzumab clinical benefit in advanced esophagogastric cancer. Future oncology (London, England) 17 (31) (2021)
Russell W Madison, Sumati V Gupta, Yasir Y Elamin, Douglas I Lin, Sumanta Kumar Pal, Andrea Necchi, Vincent A Miller, Jeffrey S Ross, Jon H Chung, Brian M Alexander, Alexa B Schrock, John V Heymach, Prasanth Reddy, Siraj M Ali
Urothelial cancer harbours EGFR and HER2 amplifications and exon 20 insertions. BJU international 125 (5) (2020)
Alexa B Schrock, Russell W Madison, Mark Rosenzweig, Justin M Allen, Rachel L Erlich, Siao-Yi Wang, Tarek Chidiac, Vodur Suresh Reddy, Jonathan W Riess, Ahmet Ersin Yassa, Abdur Shakir, Vincent A Miller, Brian M Alexander, Jeffrey Venstrom, Kimberly McGregor, Siraj M Ali
Patients with NSCLCs Harboring Internal Inversions or Deletion Rearrangements of the ALK Gene Have Durable Responses to ALK Kinase Inhibitors. Lung Cancer (Auckland, N.Z.) 11 (2020)
Kyriakos P Papadopoulos, Erkut Hasan Borazanci, Alice T Shaw, Ryohei Katayama, Yuki Shimizu, Viola W Zhu, Thomas Yang Sun, Heather A Wakelee, Russell W Madison, Alexa B Schrock, Giorgio Senaldi, Naoki Nakao, Hiroyuki Hanzawa, Masaya Tachibana, Takeshi Isoyama, Kenji Nakamaru, Chenhui Deng, Meijing Li, Frank Fan, Qinying Zhao, Yanfei Gao, Takashi Seto, Pasi A Jänne, Sai-Hong Ignatius Ou
U.S. Phase I First-in-human Study of Taletrectinib (DS-6051b/AB-106), a ROS1/TRK Inhibitor, in Patients with Advanced Solid Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (18) (2020)
Filippo Pederzoli, Marco Bandini, Laura Marandino, Siraj M Ali, Russell W Madison, Jon Chung, Jeffrey S Ross, Andrea Necchi
Targetable gene fusions and aberrations in genitourinary oncology. Nature reviews. Urology 17 (11) (2020)